The Impact of Smoking on Post-Clopidogrel Platelet Reactivity in Patients With Acute Myocardial Infarction
Smoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However, an association between pre-admission smoking (PS) and post-clopidogrel platelet reactivity in patients with acute myocardial infarction (AMI) has not been determined. S...
Saved in:
Published in | Korean circulation journal Vol. 40; no. 3; pp. 119 - 124 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Society of Cardiology
01.03.2010
대한심장학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1738-5520 1738-5555 1738-5555 |
DOI | 10.4070/kcj.2010.40.3.119 |
Cover
Abstract | Smoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However, an association between pre-admission smoking (PS) and post-clopidogrel platelet reactivity in patients with acute myocardial infarction (AMI) has not been determined.
Study cohorts were recruited from a pool of patients at our hospital who were undergoing coronary stenting for AMI (n=134). Immediately after arrival at the emergency room (ER), all patients received a 600 mg loading dose of clopidogrel followed by a maintenance dose of 75 mg/day. Platelet aggregation was measured with light transmittance aggregometry (LTA) after addition of 5 or 20 micromol/L adenosine diphosphate (ADP).
Maximal platelet aggregation (Agg(max)) was lower in PS patients after 5 micromol/L ADP (43.6+/-15.7% vs. 48.4+/-12.5%, p=0.096) and 20 micromol/L ADP stimuli (56.2+/-15.6% vs. 61.3+/-11.6%, p=0.073) compared with non-smoking (NS) patients. However, there were no differences in 5 micromol/L (42.6+/-16.3% vs. 43.8+/-15.6%, p=0.776) and 20 micromol/L ADP-induced Agg(max) (54.8+/-14.3% vs. 56.5+/-15.9%, p=0.692) between PS patients <0.5 pack/day and >/=0.5 pack/day. Although more PS patients met the criteria for low post-clopidogrel platelet reactivity (LPPR) (</=37%; the lowest quartile of 5 micromol/L ADP-induced Agg(max)) than NS patients (30.9% vs. 13.5%, p=0.048), advancing age was the only independent predictor of LPPR {odds ratio (OR) 0.960, 95% confidence interval (CI) 0.929 to 0.993, p=0.019}.
PS is significantly not associated with decreased residual platelet reactivity in AMI patients. |
---|---|
AbstractList | Smoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However, an association between pre-admission smoking (PS) and post-clopidogrel platelet reactivity in patients with acute myocardial infarction (AMI) has not been determined.BACKGROUND AND OBJECTIVESSmoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However, an association between pre-admission smoking (PS) and post-clopidogrel platelet reactivity in patients with acute myocardial infarction (AMI) has not been determined.Study cohorts were recruited from a pool of patients at our hospital who were undergoing coronary stenting for AMI (n=134). Immediately after arrival at the emergency room (ER), all patients received a 600 mg loading dose of clopidogrel followed by a maintenance dose of 75 mg/day. Platelet aggregation was measured with light transmittance aggregometry (LTA) after addition of 5 or 20 micromol/L adenosine diphosphate (ADP).SUBJECTS AND METHODSStudy cohorts were recruited from a pool of patients at our hospital who were undergoing coronary stenting for AMI (n=134). Immediately after arrival at the emergency room (ER), all patients received a 600 mg loading dose of clopidogrel followed by a maintenance dose of 75 mg/day. Platelet aggregation was measured with light transmittance aggregometry (LTA) after addition of 5 or 20 micromol/L adenosine diphosphate (ADP).Maximal platelet aggregation (Agg(max)) was lower in PS patients after 5 micromol/L ADP (43.6+/-15.7% vs. 48.4+/-12.5%, p=0.096) and 20 micromol/L ADP stimuli (56.2+/-15.6% vs. 61.3+/-11.6%, p=0.073) compared with non-smoking (NS) patients. However, there were no differences in 5 micromol/L (42.6+/-16.3% vs. 43.8+/-15.6%, p=0.776) and 20 micromol/L ADP-induced Agg(max) (54.8+/-14.3% vs. 56.5+/-15.9%, p=0.692) between PS patients <0.5 pack/day and >/=0.5 pack/day. Although more PS patients met the criteria for low post-clopidogrel platelet reactivity (LPPR) (</=37%; the lowest quartile of 5 micromol/L ADP-induced Agg(max)) than NS patients (30.9% vs. 13.5%, p=0.048), advancing age was the only independent predictor of LPPR {odds ratio (OR) 0.960, 95% confidence interval (CI) 0.929 to 0.993, p=0.019}.RESULTSMaximal platelet aggregation (Agg(max)) was lower in PS patients after 5 micromol/L ADP (43.6+/-15.7% vs. 48.4+/-12.5%, p=0.096) and 20 micromol/L ADP stimuli (56.2+/-15.6% vs. 61.3+/-11.6%, p=0.073) compared with non-smoking (NS) patients. However, there were no differences in 5 micromol/L (42.6+/-16.3% vs. 43.8+/-15.6%, p=0.776) and 20 micromol/L ADP-induced Agg(max) (54.8+/-14.3% vs. 56.5+/-15.9%, p=0.692) between PS patients <0.5 pack/day and >/=0.5 pack/day. Although more PS patients met the criteria for low post-clopidogrel platelet reactivity (LPPR) (</=37%; the lowest quartile of 5 micromol/L ADP-induced Agg(max)) than NS patients (30.9% vs. 13.5%, p=0.048), advancing age was the only independent predictor of LPPR {odds ratio (OR) 0.960, 95% confidence interval (CI) 0.929 to 0.993, p=0.019}.PS is significantly not associated with decreased residual platelet reactivity in AMI patients.CONCLUSIONPS is significantly not associated with decreased residual platelet reactivity in AMI patients. Smoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However, an association between pre-admission smoking (PS) and post-clopidogrel platelet reactivity in patients with acute myocardial infarction (AMI) has not been determined. Study cohorts were recruited from a pool of patients at our hospital who were undergoing coronary stenting for AMI (n=134). Immediately after arrival at the emergency room (ER), all patients received a 600 mg loading dose of clopidogrel followed by a maintenance dose of 75 mg/day. Platelet aggregation was measured with light transmittance aggregometry (LTA) after addition of 5 or 20 micromol/L adenosine diphosphate (ADP). Maximal platelet aggregation (Agg(max)) was lower in PS patients after 5 micromol/L ADP (43.6+/-15.7% vs. 48.4+/-12.5%, p=0.096) and 20 micromol/L ADP stimuli (56.2+/-15.6% vs. 61.3+/-11.6%, p=0.073) compared with non-smoking (NS) patients. However, there were no differences in 5 micromol/L (42.6+/-16.3% vs. 43.8+/-15.6%, p=0.776) and 20 micromol/L ADP-induced Agg(max) (54.8+/-14.3% vs. 56.5+/-15.9%, p=0.692) between PS patients <0.5 pack/day and >/=0.5 pack/day. Although more PS patients met the criteria for low post-clopidogrel platelet reactivity (LPPR) (</=37%; the lowest quartile of 5 micromol/L ADP-induced Agg(max)) than NS patients (30.9% vs. 13.5%, p=0.048), advancing age was the only independent predictor of LPPR {odds ratio (OR) 0.960, 95% confidence interval (CI) 0.929 to 0.993, p=0.019}. PS is significantly not associated with decreased residual platelet reactivity in AMI patients. Background and Objectives: Smoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However, an association between pre-admission smoking (PS) and post-clopidogrel platelet reactivity in patients with acute myocardial infarction (AMI) has not been determined. Subjects and Methods: Study cohorts were recruited from a pool of patients at our hospital who were undergoing coronary stenting for AMI (n=134). Immediately after arrival at the emergency room (ER), all patients received a 600mg loading dose of clopidogrel followed by a maintenance dose of 75 mg/day. Platelet aggregation was measured with light transmittance aggregometry (LTA) after addition of 5 or 20 μmol/L adenosine diphosphate (ADP). Results: Maximal platelet aggregation (Aggmax) was lower in PS patients after 5 μmol/L ADP (43.6±15.7% vs. 48.4±12.5%, p=0.096) and 20 μmol/L ADP stimuli (56.2±15.6% vs. 61.3±11.6%, p=0.073) compared with non-smoking (NS) patients. However, there were no differences in 5 μmol/L (42.6±16.3% vs. 43.8±15.6%,p=0.776) and 20 μmol/L ADP-induced Aggmax (54.8±14.3% vs. 56.5±15.9%, p=0.692) between PS patients <0.5 pack/day and ≥0.5 pack/day. Although more PS patients met the criteria for low post-clopidogrel platelet reactivity (LPPR) (≤37%; the lowest quartile of 5 μmol/L ADP-induced Aggmax) than NS patients (30.9% vs. 13.5%, p=0.048), advancing age was the only independent predictor of LPPR {odds ratio (OR) 0.960, 95%confidence interval (CI) 0.929 to 0.993, p=0.019}. Conclusion: PS is significantly not associated with decreased residual platelet reactivity in AMI patients. KCI Citation Count: 1 |
Author | Koh, Jin-Sin Kwak, Choong Hwan Kang, Min-Kyung Hwang, Jin-Yong Kim, In-Suk Ahn, Yeon-Jeong Hwang, Seok-Jae Jeong, Young-Hoon Park, Yongwhi Cho, Jung-Hyun |
AuthorAffiliation | 1 Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea 2 Department of Laboratory Medicine, Gyeongsang National University Hospital, Jinju, Korea |
AuthorAffiliation_xml | – name: 1 Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea – name: 2 Department of Laboratory Medicine, Gyeongsang National University Hospital, Jinju, Korea |
Author_xml | – sequence: 1 givenname: Jung-Hyun surname: Cho fullname: Cho, Jung-Hyun organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea – sequence: 2 givenname: Young-Hoon surname: Jeong fullname: Jeong, Young-Hoon organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea – sequence: 3 givenname: Yeon-Jeong surname: Ahn fullname: Ahn, Yeon-Jeong organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea – sequence: 4 givenname: Min-Kyung surname: Kang fullname: Kang, Min-Kyung organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea – sequence: 5 givenname: Jin-Sin surname: Koh fullname: Koh, Jin-Sin organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea – sequence: 6 givenname: In-Suk surname: Kim fullname: Kim, In-Suk organization: Department of Laboratory Medicine, Gyeongsang National University Hospital, Jinju, Korea – sequence: 7 givenname: Yongwhi surname: Park fullname: Park, Yongwhi organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea – sequence: 8 givenname: Seok-Jae surname: Hwang fullname: Hwang, Seok-Jae organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea – sequence: 9 givenname: Choong Hwan surname: Kwak fullname: Kwak, Choong Hwan organization: Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea – sequence: 10 givenname: Jin-Yong surname: Hwang fullname: Hwang, Jin-Yong organization: Division of Cardiology, Departments of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20339496$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001431846$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1kV-PEyEUxYlZ4_7RD-CL4c34MBUGZhheTJpG3SZr3Kw1PhKGgZaWgQp0k357abu7WU3k5XLD75yTy70EZz54DcBbjCYUMfRxo9aTGh27CZlgzF-AC8xIVzXlnD3da3QOLlNaI9RSWvNX4LxGhHDK2wuwXqw0nI9bqTIMBv4Yw8b6JQwe3oaUq5kLWzuEZdQO3jqZtdMZ3ulC23ub99AWTmarfU7wl80rOFW7rOG3fVAyDlY6OPdGxoIH_xq8NNIl_eahXoGfXz4vZtfVzfev89n0plKEMl6Rumc9U23PGq7bgRmlGkKMHnQrEcO4UahFTKKBStV0ElFkuhb3piHdoHEvyRX4cPL10YiNsiJIe6zLIDZRTO8Wc4Ex4zWnhf10Yre7ftSDKoNE6cQ22lHG_VH594u3q-JzL-qOUs5YMXj_YBDD751OWYw2Ke2c9DrskmCEdJhwVBfy3fOop4zHXRSAnQAVQ0pRG6FsloefK8nWCYzEYetllLU4bL10gpRJeFHif5SP5v_X_AFhzbF_ |
CitedBy_id | crossref_primary_10_1016_j_ahj_2011_06_005 crossref_primary_10_1007_s11886_013_0361_7 crossref_primary_10_1016_j_jcin_2016_06_042 crossref_primary_10_1007_s10554_011_9964_5 crossref_primary_10_1016_j_ahj_2012_12_024 crossref_primary_10_1080_09537104_2019_1572878 crossref_primary_10_1136_heartjnl_2013_304138 crossref_primary_10_1016_j_jacc_2013_10_043 crossref_primary_10_4070_kcj_2010_40_3_112 |
Cites_doi | 10.1016/j.jacc.2008.12.044 10.1016/j.jacc.2003.12.047 10.1016/j.jacc.2007.01.094 10.4070/kcj.2008.38.3.161 10.1016/j.jacc.2008.12.025 10.1161/CIRCULATIONAHA.106.675934 10.1038/ncpcardio0602 10.2217/14622416.9.9.1251 10.1016/j.jacc.2008.04.045 10.1016/j.jacc.2007.12.056 10.1161/01.CIR.0000130846.46168.03 10.1016/S0090-9556(24)15013-1 10.2165/00003088-199936060-00004 10.1093/eurheartj/ehn313 10.1161/01.CIR.0000047060.60595.CC 10.1016/S0140-6736(06)69249-0 10.1056/NEJMe0810513 10.1161/01.CIR.94.12.3109 10.1016/j.jacc.2007.06.064 10.1111/j.1538-7836.2007.02812.x 10.4070/kcj.2005.35.8.613 10.1161/CIRCULATIONAHA.109.866533 10.1016/j.jacc.2008.07.055 10.1016/S0049-3848(98)00184-4 10.1056/NEJMoa0809171 10.1038/35051599 10.4070/kcj.2007.37.8.373 10.1097/00005344-200210000-00010 |
ContentType | Journal Article |
Copyright | Copyright © 2010 The Korean Society of Cardiology 2010 |
Copyright_xml | – notice: Copyright © 2010 The Korean Society of Cardiology 2010 |
DBID | AAYXX CITATION NPM 7X8 5PM ACYCR |
DOI | 10.4070/kcj.2010.40.3.119 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1738-5555 |
EndPage | 124 |
ExternalDocumentID | oai_kci_go_kr_ARTI_1179294 PMC2844977 20339496 10_4070_kcj_2010_40_3_119 |
Genre | Journal Article |
GroupedDBID | --- 5-W 8JR 8XY 9ZL AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK E3Z EF. F5P HYE KQ8 M48 O5R O5S OK1 PGMZT RPM NPM 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c3479-32b7b7c6b759e6d7fcc533fede6a07115c0607a0d4ac58a040f861bf538de1ba3 |
IEDL.DBID | M48 |
ISSN | 1738-5520 1738-5555 |
IngestDate | Sun Mar 09 08:00:04 EDT 2025 Thu Aug 21 18:28:01 EDT 2025 Fri Jul 11 11:46:28 EDT 2025 Wed Apr 02 03:48:17 EDT 2025 Tue Aug 05 11:59:45 EDT 2025 Thu Apr 24 23:07:34 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Acute myocardial infarction Post-clopidogrel platelet reactivity Smoking |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3479-32b7b7c6b759e6d7fcc533fede6a07115c0607a0d4ac58a040f861bf538de1ba3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-000708.2010.40.3.001 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.4070/kcj.2010.40.3.119 |
PMID | 20339496 |
PQID | 733813902 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_1179294 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2844977 proquest_miscellaneous_733813902 pubmed_primary_20339496 crossref_citationtrail_10_4070_kcj_2010_40_3_119 crossref_primary_10_4070_kcj_2010_40_3_119 |
PublicationCentury | 2000 |
PublicationDate | 20100301 |
PublicationDateYYYYMMDD | 2010-03-01 |
PublicationDate_xml | – month: 3 year: 2010 text: 20100301 day: 1 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Korean circulation journal |
PublicationTitleAlternate | Korean Circ J |
PublicationYear | 2010 |
Publisher | The Korean Society of Cardiology 대한심장학회 |
Publisher_xml | – name: The Korean Society of Cardiology – name: 대한심장학회 |
References | Lim (10.4070/kcj.2010.40.3.119_ref19) 2005; 35 Ambrose (10.4070/kcj.2010.40.3.119_ref17) 2004; 43 Jeong (10.4070/kcj.2010.40.3.119_ref11) 2008; 29 Jeong (10.4070/kcj.2010.40.3.119_ref10) 2009; 53 Buonamici (10.4070/kcj.2010.40.3.119_ref8) 2007; 49 Geisler (10.4070/kcj.2010.40.3.119_ref28) 2008; 6 Siller-Matula (10.4070/kcj.2010.40.3.119_ref2) 2008; 52 Freedman (10.4070/kcj.2010.40.3.119_ref26) 2009; 360 Luscher (10.4070/kcj.2010.40.3.119_ref24) 2007; 115 Teo (10.4070/kcj.2010.40.3.119_ref16) 2006; 368 Lau (10.4070/kcj.2010.40.3.119_ref5) 2003; 107 Bliden (10.4070/kcj.2010.40.3.119_ref7) 2008; 52 Iba (10.4070/kcj.2010.40.3.119_ref12) 1999; 27 Cho (10.4070/kcj.2010.40.3.119_ref18) 2008; 38 Ichiki (10.4070/kcj.2010.40.3.119_ref22) 1996; 94 Matetzky (10.4070/kcj.2010.40.3.119_ref9) 2004; 109 Zevin (10.4070/kcj.2010.40.3.119_ref6) 1999; 36 Geisler (10.4070/kcj.2010.40.3.119_ref29) 2008; 9 Desai (10.4070/kcj.2010.40.3.119_ref15) 2009; 53 Berger (10.4070/kcj.2010.40.3.119_ref14) 2009; 120 Fusegawa (10.4070/kcj.2010.40.3.119_ref21) 1999; 93 Mega (10.4070/kcj.2010.40.3.119_ref25) 2009; 360 Hollopeter (10.4070/kcj.2010.40.3.119_ref1) 2001; 409 Sawada (10.4070/kcj.2010.40.3.119_ref23) 2002; 40 Trenk (10.4070/kcj.2010.40.3.119_ref4) 2008; 51 Gilard (10.4070/kcj.2010.40.3.119_ref3) 2008; 51 Cho (10.4070/kcj.2010.40.3.119_ref20) 2007; 37 Tantcheva-Poor (10.4070/kcj.2010.40.3.119_ref13) 1999; 9 Gurbel (10.4070/kcj.2010.40.3.119_ref27) 2006; 3 18781853 - Pharmacogenomics. 2008 Sep;9(9):1251-9 8989117 - Circulation. 1996 Dec 15;94(12):3109-14 10376760 - Pharmacogenetics. 1999 Apr;9(2):131-44 19007592 - J Am Coll Cardiol. 2008 Nov 4;52(19):1557-63 19106084 - N Engl J Med. 2009 Jan 22;360(4):354-62 16920470 - Lancet. 2006 Aug 19;368(9536):647-58 19933933 - Circulation. 2009 Dec 8;120(23):2337-44 18206732 - J Am Coll Cardiol. 2008 Jan 22;51(3):256-60 11196645 - Nature. 2001 Jan 11;409(6817):202-7 19164193 - N Engl J Med. 2009 Jan 22;360(4):411-3 18617479 - Eur Heart J. 2008 Sep;29(17):2186-7; author reply 2187 17572245 - J Am Coll Cardiol. 2007 Jun 19;49(24):2312-7 19358940 - J Am Coll Cardiol. 2009 Apr 14;53(15):1273-8 10093968 - Thromb Res. 1999 Mar 15;93(6):271-8 12515739 - Circulation. 2003 Jan 7;107(1):32-7 15145091 - J Am Coll Cardiol. 2004 May 19;43(10):1731-7 10460794 - Drug Metab Dispos. 1999 Sep;27(9):977-82 19324253 - J Am Coll Cardiol. 2009 Mar 31;53(13):1101-9 10427467 - Clin Pharmacokinet. 1999 Jun;36(6):425-38 18482659 - J Am Coll Cardiol. 2008 May 20;51(20):1925-34 16810174 - Nat Clin Pract Cardiovasc Med. 2006 Jul;3(7):387-95 17325255 - Circulation. 2007 Feb 27;115(8):1051-8 15184279 - Circulation. 2004 Jun 29;109(25):3171-5 12352319 - J Cardiovasc Pharmacol. 2002 Oct;40(4):571-6 17949474 - J Thromb Haemost. 2008 Jan;6(1):54-61 18687246 - J Am Coll Cardiol. 2008 Aug 12;52(7):531-3 |
References_xml | – volume: 53 start-page: 1273 year: 2009 ident: 10.4070/kcj.2010.40.3.119_ref15 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.12.044 – volume: 43 start-page: 1731 year: 2004 ident: 10.4070/kcj.2010.40.3.119_ref17 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2003.12.047 – volume: 49 start-page: 2312 year: 2007 ident: 10.4070/kcj.2010.40.3.119_ref8 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2007.01.094 – volume: 38 start-page: 161 year: 2008 ident: 10.4070/kcj.2010.40.3.119_ref18 publication-title: Korean Circ J doi: 10.4070/kcj.2008.38.3.161 – volume: 53 start-page: 1101 year: 2009 ident: 10.4070/kcj.2010.40.3.119_ref10 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.12.025 – volume: 115 start-page: 1051 year: 2007 ident: 10.4070/kcj.2010.40.3.119_ref24 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.675934 – volume: 3 start-page: 387 year: 2006 ident: 10.4070/kcj.2010.40.3.119_ref27 publication-title: Nat Clin Pract Cardiovasc Med doi: 10.1038/ncpcardio0602 – volume: 9 start-page: 1251 year: 2008 ident: 10.4070/kcj.2010.40.3.119_ref29 publication-title: Pharmacogenomics doi: 10.2217/14622416.9.9.1251 – volume: 9 start-page: 131 year: 1999 ident: 10.4070/kcj.2010.40.3.119_ref13 publication-title: Pharmacogenetics – volume: 52 start-page: 531 year: 2008 ident: 10.4070/kcj.2010.40.3.119_ref7 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.04.045 – volume: 51 start-page: 1925 year: 2008 ident: 10.4070/kcj.2010.40.3.119_ref4 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2007.12.056 – volume: 109 start-page: 3171 year: 2004 ident: 10.4070/kcj.2010.40.3.119_ref9 publication-title: Circulation doi: 10.1161/01.CIR.0000130846.46168.03 – volume: 27 start-page: 977 year: 1999 ident: 10.4070/kcj.2010.40.3.119_ref12 publication-title: Drug Metab Dispos doi: 10.1016/S0090-9556(24)15013-1 – volume: 36 start-page: 425 year: 1999 ident: 10.4070/kcj.2010.40.3.119_ref6 publication-title: Clin Pharmacokinet doi: 10.2165/00003088-199936060-00004 – volume: 29 start-page: 2186 year: 2008 ident: 10.4070/kcj.2010.40.3.119_ref11 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehn313 – volume: 107 start-page: 32 year: 2003 ident: 10.4070/kcj.2010.40.3.119_ref5 publication-title: Circulation doi: 10.1161/01.CIR.0000047060.60595.CC – volume: 368 start-page: 647 year: 2006 ident: 10.4070/kcj.2010.40.3.119_ref16 publication-title: Lancet doi: 10.1016/S0140-6736(06)69249-0 – volume: 360 start-page: 411 year: 2009 ident: 10.4070/kcj.2010.40.3.119_ref26 publication-title: N Engl J Med doi: 10.1056/NEJMe0810513 – volume: 94 start-page: 3109 year: 1996 ident: 10.4070/kcj.2010.40.3.119_ref22 publication-title: Circulation doi: 10.1161/01.CIR.94.12.3109 – volume: 51 start-page: 256 year: 2008 ident: 10.4070/kcj.2010.40.3.119_ref3 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2007.06.064 – volume: 6 start-page: 54 year: 2008 ident: 10.4070/kcj.2010.40.3.119_ref28 publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2007.02812.x – volume: 35 start-page: 613 year: 2005 ident: 10.4070/kcj.2010.40.3.119_ref19 publication-title: Korean Circ J doi: 10.4070/kcj.2005.35.8.613 – volume: 120 start-page: 2337 year: 2009 ident: 10.4070/kcj.2010.40.3.119_ref14 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.866533 – volume: 52 start-page: 1557 year: 2008 ident: 10.4070/kcj.2010.40.3.119_ref2 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2008.07.055 – volume: 93 start-page: 271 year: 1999 ident: 10.4070/kcj.2010.40.3.119_ref21 publication-title: Thromb Res doi: 10.1016/S0049-3848(98)00184-4 – volume: 360 start-page: 354 year: 2009 ident: 10.4070/kcj.2010.40.3.119_ref25 publication-title: N Engl J Med doi: 10.1056/NEJMoa0809171 – volume: 409 start-page: 202 year: 2001 ident: 10.4070/kcj.2010.40.3.119_ref1 publication-title: Nature doi: 10.1038/35051599 – volume: 37 start-page: 373 year: 2007 ident: 10.4070/kcj.2010.40.3.119_ref20 publication-title: Korean Circ J doi: 10.4070/kcj.2007.37.8.373 – volume: 40 start-page: 571 year: 2002 ident: 10.4070/kcj.2010.40.3.119_ref23 publication-title: J Cardiovasc Pharmacol doi: 10.1097/00005344-200210000-00010 – reference: 8989117 - Circulation. 1996 Dec 15;94(12):3109-14 – reference: 16810174 - Nat Clin Pract Cardiovasc Med. 2006 Jul;3(7):387-95 – reference: 18781853 - Pharmacogenomics. 2008 Sep;9(9):1251-9 – reference: 10427467 - Clin Pharmacokinet. 1999 Jun;36(6):425-38 – reference: 19007592 - J Am Coll Cardiol. 2008 Nov 4;52(19):1557-63 – reference: 16920470 - Lancet. 2006 Aug 19;368(9536):647-58 – reference: 17572245 - J Am Coll Cardiol. 2007 Jun 19;49(24):2312-7 – reference: 18617479 - Eur Heart J. 2008 Sep;29(17):2186-7; author reply 2187 – reference: 11196645 - Nature. 2001 Jan 11;409(6817):202-7 – reference: 17949474 - J Thromb Haemost. 2008 Jan;6(1):54-61 – reference: 12352319 - J Cardiovasc Pharmacol. 2002 Oct;40(4):571-6 – reference: 19324253 - J Am Coll Cardiol. 2009 Mar 31;53(13):1101-9 – reference: 19358940 - J Am Coll Cardiol. 2009 Apr 14;53(15):1273-8 – reference: 12515739 - Circulation. 2003 Jan 7;107(1):32-7 – reference: 19164193 - N Engl J Med. 2009 Jan 22;360(4):411-3 – reference: 10376760 - Pharmacogenetics. 1999 Apr;9(2):131-44 – reference: 19106084 - N Engl J Med. 2009 Jan 22;360(4):354-62 – reference: 17325255 - Circulation. 2007 Feb 27;115(8):1051-8 – reference: 18482659 - J Am Coll Cardiol. 2008 May 20;51(20):1925-34 – reference: 15145091 - J Am Coll Cardiol. 2004 May 19;43(10):1731-7 – reference: 10093968 - Thromb Res. 1999 Mar 15;93(6):271-8 – reference: 18687246 - J Am Coll Cardiol. 2008 Aug 12;52(7):531-3 – reference: 19933933 - Circulation. 2009 Dec 8;120(23):2337-44 – reference: 18206732 - J Am Coll Cardiol. 2008 Jan 22;51(3):256-60 – reference: 10460794 - Drug Metab Dispos. 1999 Sep;27(9):977-82 – reference: 15184279 - Circulation. 2004 Jun 29;109(25):3171-5 |
SSID | ssj0064429 |
Score | 1.8288299 |
Snippet | Smoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However, an association between... Background and Objectives: Smoking increases inhibition of clopidogrel-induced platelet reactivity in patients undergoing elective coronary stenting. However,... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 119 |
SubjectTerms | Original 내과학 |
Title | The Impact of Smoking on Post-Clopidogrel Platelet Reactivity in Patients With Acute Myocardial Infarction |
URI | https://www.ncbi.nlm.nih.gov/pubmed/20339496 https://www.proquest.com/docview/733813902 https://pubmed.ncbi.nlm.nih.gov/PMC2844977 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001431846 |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Korean Circulation Journal, 2010, 40(3), , pp.119-124 |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1738-5555 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064429 issn: 1738-5520 databaseCode: KQ8 dateStart: 20090101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1738-5555 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064429 issn: 1738-5520 databaseCode: DIK dateStart: 20050101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 1738-5555 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064429 issn: 1738-5520 databaseCode: 5-W dateStart: 20050101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1738-5555 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064429 issn: 1738-5520 databaseCode: RPM dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1738-5555 dateEnd: 20250331 omitProxy: true ssIdentifier: ssj0064429 issn: 1738-5520 databaseCode: M48 dateStart: 20090301 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEA93J4gv4rf1iyA-CT3T5rNPchwet8KKqIv3FpI08fautnf7Ad5_78y2u7iyCD6VtGlD85vp_KbJzBDyhofEvY4sdxXzufBlnRtTuFw6XxlugpAag5PHn9TpRHw8k2d7ZF3eapjA-U7XDutJTWbN4a_rm_eg8MBfD8EdYe8uw0W_R0uACwrfgGqf3ALDVKKQj8VmUQEs_6poWaFBx6Ush0XO3Y_YMlP77SztYqB_b6T8wzKd3CN3B0pJj3oZuE_2YvuA3B4Pi-YPyQWIAh2toiFpl-jXnx3-HqddS7FSb36MMVN1B353Qz83QD0BSfolYsAD1pWgU-jXJ1-d0-_TxTk9CstFpOMbsIIoXQ0dtQnUBRF-RCYnH74dn-ZDiYU8YAhpzkuvvQ7Ka1lFVesUAvC_FOuoHJCPQgammHasFi5I40Djk1GFT_CZrGPhHX9MDtqujU8JDbEyypgoa-BoWihoOCAHiicsHZ5SRth6Rm0Y8o9jGYzGgh-CIFgAwSII0LIcXJMqI283t1z1yTf-1fk1wATnpxZTZuPxR2cvZxYcgxHmNAciKDJC1yha0CNcHHFt7JZzq8FXBzbMyow86UHdDFkyzitRqYzoLbg3HXC87Svt9HyVqhuMvwCG_ex_XuQ5udNvUcCNbi_IwWK2jC-B-Sz8q5U8_wZzaf9T |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Impact+of+Smoking+on+Post-Clopidogrel+Platelet+Reactivity+in+Patients+With+Acute+Myocardial+Infarction&rft.jtitle=Korean+circulation+journal&rft.au=Cho%2C+Jung-Hyun&rft.au=Jeong%2C+Young-Hoon&rft.au=Ahn%2C+Yeon-Jeong&rft.au=Kang%2C+Min-Kyung&rft.date=2010-03-01&rft.issn=1738-5520&rft.volume=40&rft.issue=3&rft.spage=119&rft_id=info:doi/10.4070%2Fkcj.2010.40.3.119&rft.externalDBID=n%2Fa&rft.externalDocID=10_4070_kcj_2010_40_3_119 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-5520&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-5520&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-5520&client=summon |